Steve Jones's profile photo

Steve Jones

Sydney

Freelance Journalist at Freelance

Contributing Editor at TravelMole

Chief Correspondent at Cannabiz

Freelance journalist, contributor to @cannabiz_au, @mumbrellanews and @medicalrepublic

Featured in: Favicon travelmole.com Favicon cannabiz.com.au Favicon linkedin.com Favicon forbes.com Favicon medium.com Favicon nature.com Favicon thoughtco.com Favicon thenextweb.com Favicon cio.com Favicon thedrum.com

Articles

  • Offer tabled for Ecofibre as creditors prepare to vote on company's future

    2 days ago | cannabiz.com.au | Steve Jones

    Creditors of Ecofibre will meet for a second time tomorrow (Friday) when they are expected to accept an offer to acquire the company and save it from liquidation. Administrators for the stricken firm, KordaMentha, said the offer – from an unnamed entity – is the only way unsecured creditors will see a return, and ensure the survival of the business and jobs.

  • NZ merger 'no risk' to ethical prescribing and will grow 'stagnant' market, says clinic boss

    3 days ago | cannabiz.com.au | Steve Jones

    The boss of New Zealand’s largest medicinal cannabis clinic has insisted doctors will remain product agnostic when it merges with Helius Therapeutics as he predicted the three-way deal announced last week will help galvanise the “stagnant” sector. Dr Waseem Alzaher said prescribers at Cannabis Clinic will be under no pressure to favour Helius products once the merger is complete. Decisions will be based on the clinical needs of patients, and nothing more, he said.

  • Physicians college executive named as first CEO of Cannabis Council

    3 days ago | cannabiz.com.au | Steve Jones

    A healthcare executive with 25 years’ experience, including more than a decade with the Royal Australasian College of Physicians, is to lead Cannabis Council Australia as its first chief executive. Lisa Penlington served as executive general manager, member engagement and support during her last seven years as the RACP, which she joined in 2014 after 10 years with the Royal Australian and New Zealand College of Radiologists.

  • Cann Group and Rua Bioscience settle 15-month legal dispute

    3 days ago | cannabiz.com.au | Steve Jones

    Cann Group and Rua Bioscience have settled their commercial dispute after 15 months of legal wrangling. The terms of the agreement were not disclosed although Cann Group confirmed that no payments were made to either party.

  • PK study shows further promise for Neurotech paediatric CBDA drug

    4 days ago | cannabiz.com.au | Steve Jones

    The first human pharmacokinetics study of Neurotech International’s broad-spectrum cannabinoid treatment, NTI164, has shown positive results with rapid and predictable absorption of the drug, the company has said. The study also confirmed that CBDA was the dominant cannabinoid, with negligible levels of THC, while no significant cannabinoid accumulation was observed.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
890
Tweets
1K
DMs Open
No
Steve Jones
Steve Jones @stevepjones100
17 Apr 25

@FamiilyAu Hi, I'm a journalist trying to find a contact email address or phone number for the party. Can you help please? Many thanks

Steve Jones
Steve Jones @stevepjones100
18 Oct 23

I'm attending this event. RT if you think others will find this helpful 🙌 https://t.co/iQ47zbGq8J #australiancannabissummit2023

Steve Jones
Steve Jones @stevepjones100
26 Jun 23

ECS Botanics strikes $11.9m dried flower offtake deals https://t.co/hcA8CzSkQI